PART 7 - DANISH ATHLETE STUDY: SIDE-EFFECTS: GRAPHICAL DATA These are reference graphs supporting the discussion of Side Effects in Part 2 above. GRAPH #1 . . . SIDE-EFFECTS: OVERALL OCCURANCE GRAPH #2: SIDE-EFFECTS BY TYPE GRAPH #3: SIDE EFFECTS, DURATION NOT ASCERTAINED GRAPH #4: PERSISTANT SIDE EFFECTS BY TYPE GRAPH #5: SIDE-EFFECTS DECREASED BY LOWERING DOSAGE GRAPH #6: TRANSIENT SIDE-EFFECTS BY TYPE GRAPH #7: SUBJECTIVE BENEFITS: OVERVIEW GRAPH #8: SUBJECTIVE BENEFITS - ATHLETIC PERFORMANCE GRAPH #9: SUBJECTIVE BENEFITS - DECREASE IN INFLAMMATION GRAPH #10: SUBJECTIVE BENEFITS - EFFECT ON STRENGTH GRAPH #11: SUBJECTIVE BENEFITS - GENERAL WELL-BEING Index Part 1 Part 2 Part 3 Part 4 Part 5 Part 6A Part 6B Part 6C Part 7
PART 7 - DANISH ATHLETE STUDY: SIDE-EFFECTS: GRAPHICAL DATA
These are reference graphs supporting the discussion of Side Effects in Part 2 above.
GRAPH #1 . . . SIDE-EFFECTS: OVERALL OCCURANCE
GRAPH #2: SIDE-EFFECTS BY TYPE
GRAPH #3: SIDE EFFECTS, DURATION NOT ASCERTAINED
GRAPH #5: SIDE-EFFECTS DECREASED BY LOWERING DOSAGE
GRAPH #6: TRANSIENT SIDE-EFFECTS BY TYPE
GRAPH #7: SUBJECTIVE BENEFITS: OVERVIEW
GRAPH #8: SUBJECTIVE BENEFITS - ATHLETIC PERFORMANCE
GRAPH #9: SUBJECTIVE BENEFITS - DECREASE IN INFLAMMATION
GRAPH #10: SUBJECTIVE BENEFITS - EFFECT ON STRENGTH
GRAPH #11: SUBJECTIVE BENEFITS - GENERAL WELL-BEING
Index Part 1 Part 2 Part 3 Part 4 Part 5 Part 6A Part 6B Part 6C Part 7
